{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:06:41Z","timestamp":1777468001025,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2023,2,15]]},"abstract":"<jats:p>BACKGROUND: BRCA1\/2-associated invasive breast cancer has been extensively studied. However, there are few reports of ductal carcinoma in situ (DCIS). OBJECTIVE: This study aimed to investigate the clinicopathological and imaging findings of DCIS in patients with BRCA1\/2 mutations. METHODS: This was a single-institution, retrospective study. We identified patients diagnosed with DCIS with BRCA mutations between September 2003 and December 2020. Clinicopathological data and mammography (MG), magnetic resonance imaging (MRI), and ultrasound (US) findings were reviewed. RESULTS: We identified 30 cancers in 28 patients; 7 (25.0%) patients had BRCA1 mutations, and 21 (75.0%) had BRCA2 mutations. The median patient age was 42\u00a0years. Screening was the most common reason for the detection of DCIS (50.0%), followed by occult cancer diagnosed by pathological examination after risk-reducing mastectomy (26.7%). The nuclear grade was most often\u00a01 (46.7%), and 93.3% were estrogen and\/or progesterone receptor positive. The detection rates of MG, MRI, and US were 64.3%, 72.0%, and 64.0%, respectively. The most common imaging findings were calcification (100%) on MG, non-mass enhancement (88.9%) on MRI, and hypoechoic area (75.0%) on US. CONCLUSION: BRCA-associated DCIS was more strongly associated with BRCA2, and imaging features were similar to those of sporadic DCIS. Our results are helpful in informing surveillance strategies based on genotypes in women with BRCA mutations.<\/jats:p>","DOI":"10.3233\/bd-220006","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T11:47:18Z","timestamp":1676634438000},"page":"5-15","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological and imaging features of\u00a0ductal carcinoma in situ in BRCA1\/2 mutation carriers"],"prefix":"10.1177","volume":"42","author":[{"given":"Akina","family":"Seki","sequence":"first","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Tsunoda","sequence":"additional","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takei","sequence":"additional","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Suzuki","sequence":"additional","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kanomata","sequence":"additional","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Yamauchi","sequence":"additional","affiliation":[{"name":", St.\u00a0Luke\u2019s International Hospital, , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/BD-220006_ref1","unstructured":"American College of Radiology. ACR BI-RADS atlas: Breast Imaging Reporting and Data System. American College of Radiology (Reston, VA), 2014, 37\u201378, 2013."},{"key":"10.3233\/BD-220006_ref2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jama.293.8.964","article-title":"Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ","volume":"293","author":"Claus","year":"2005","journal-title":"JAMA"},{"key":"10.3233\/BD-220006_ref3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.sult.2017.08.002","article-title":"Role of digital breast tomosynthesis in screening and diagnostic breast imaging","volume":"39","author":"Destounis","year":"2018","journal-title":"Semin Ultrasound CT MR"},{"key":"10.3233\/BD-220006_ref4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2214\/ajr.16.16957","article-title":"Association of BRCA mutation types, imaging features, and pathologic findings in patients with breast cancer with BRCA1 and BRCA2 mutations","volume":"209","author":"Ha","year":"2017","journal-title":"AJR Am\u00a0J Roentgenol"},{"key":"10.3233\/BD-220006_ref5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1158\/1940-6207.CAPR-09-0218","article-title":"Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma in situ and referred for genetic testing","volume":"3","author":"Hall","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.3233\/BD-220006_ref6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/jco.2005.04.0345","article-title":"Ductal carcinoma in situ in BRCA mutation carriers","volume":"25","author":"Hwang","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.3233\/BD-220006_ref7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","article-title":"Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers","volume":"163","author":"Krammer","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-220006_ref8","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","article-title":"Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial","volume":"28","author":"Kuhl","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.3233\/BD-220006_ref9","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1002\/mgg3.493","article-title":"BRCA1\/BRCA2 mutations in Japanese women with ductal carcinoma in situ","volume":"7","author":"Liu","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"10.3233\/BD-220006_ref10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12282-019-00955-6","article-title":"The clinical impact of MRI screening for BRCA mutation carriers: The first report in Japan","volume":"26","author":"Murakami","year":"2019","journal-title":"Breast Cancer"},{"key":"10.3233\/BD-220006_ref11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7326\/M15-0971","article-title":"Factors associated with rates of false-positive and false-negative results from digital mammography screening: An analysis of registry data","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.3233\/BD-220006_ref12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12282-020-01203-y","article-title":"Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan","volume":"28","author":"Ohnuki","year":"2021","journal-title":"Breast Cancer"},{"key":"10.3233\/BD-220006_ref13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","article-title":"Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density","volume":"33","author":"Riedl","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.3233\/BD-220006_ref14","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC screening study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.3233\/BD-220006_ref15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer\u00a0J Clin"},{"key":"10.3233\/BD-220006_ref16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s12282-017-0763-2","article-title":"Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women","volume":"24","author":"Sawada","year":"2017","journal-title":"Breast Cancer"},{"key":"10.3233\/BD-220006_ref17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1148\/radiol.2461062173","article-title":"Mammographic, US, and MR imaging phenotypes of familial breast cancer","volume":"246","author":"Schrading","year":"2008","journal-title":"Radiology"},{"key":"10.3233\/BD-220006_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-020-01103-1"},{"key":"10.3233\/BD-220006_ref19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-018-1019-6","article-title":"The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI","volume":"20","author":"Vreemann","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.3233\/BD-220006_ref20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1524-4741.2010.01018.x","article-title":"Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study","volume":"17","author":"Warner","year":"2011","journal-title":"Breast\u00a0J"},{"key":"10.3233\/BD-220006_ref21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"key":"10.3233\/BD-220006_ref22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ultrasmedbio.2017.01.008","article-title":"Ultrasound image classification of ductal carcinoma in situ (DCIS) of the breast: analysis of 705 DCIS lesions","volume":"43","author":"Watanabe","year":"2017","journal-title":"Ultrasound Med Biol"},{"key":"10.3233\/BD-220006_ref23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10549-018-4953-1","article-title":"High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: Findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan","volume":"172","author":"Yamauchi","year":"2018","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-220006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:30Z","timestamp":1777383150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-220006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":23,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/bd-220006","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}